Based on 1 analyst offering 12 month price targets for Mainz Biomed Nv
Min Forecast
$14.00+308.16%
Avg Forecast
$14.00+308.16%
Max Forecast
$14.00+308.16%
Should I buy or sell MYNZ stock?
Based on 1 analyst offering ratings for Mainz Biomed Nv.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MYNZ's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates MYNZ as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More
Be the first to know when Wall Street analysts revise their MYNZ stock forecasts and price targets.
Is Mainz Biomed Nv Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: MYNZ) stock is to Strong Buy MYNZ stock.
Out of 1 analyst, 1 (100%) are recommending MYNZ as a Strong Buy, 0 (0%) are recommending MYNZ as a Buy, 0 (0%) are recommending MYNZ as a Hold, 0 (0%) are recommending MYNZ as a Sell, and 0 (0%) are recommending MYNZ as a Strong Sell.
What is MYNZ's earnings growth forecast for 2025-2025?
(NASDAQ: MYNZ) Mainz Biomed Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Mainz Biomed Nv's earnings in 2025 is -$21,650,663.
In 2025, MYNZ is forecast to generate -$21,338,048 in earnings, with the lowest earnings forecast at -$21,338,048 and the highest earnings forecast at -$21,338,048.
What is MYNZ's revenue growth forecast for 2025-2025?
(NASDAQ: MYNZ) Mainz Biomed Nv's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Mainz Biomed Nv's revenue in 2025 is $893,991.
In 2025, MYNZ is forecast to generate $3,247,094 in revenue, with the lowest revenue forecast at $3,247,094 and the highest revenue forecast at $3,247,094.
What is MYNZ's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: MYNZ) forecast ROA is -161.19%, which is lower than the forecast US Diagnostics & Research industry average of 8.82%.
What is MYNZ's Price Target?
According to 1 Wall Street analyst that have issued a 1 year MYNZ price target, the average MYNZ price target is $14.00, with the highest MYNZ stock price forecast at $14.00 and the lowest MYNZ stock price forecast at $14.00.
The Wall Street analyst predicted that Mainz Biomed Nv's share price could reach $14.00 by Feb 14, 2026. The average Mainz Biomed Nv stock price prediction forecasts a potential upside of 308.16% from the current MYNZ share price of $3.43.
What is MYNZ's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: MYNZ) Mainz Biomed Nv's current Earnings Per Share (EPS) is -$22.36. In 2025, MYNZ's EPS is forecast to hit -$9.20 (min: -$9.20, max: -$9.20).
What is MYNZ's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: MYNZ) forecast ROE is -352.9%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.